Influenza virus infection and risk of acute myocardial infarction

Inflammation

Volumn 31, Issue 4, 2008, Pages 266-272

  Guan, Xiu Ru ^a   Li, Xin ^a   Xin, Xiao Min ^a   Jiang, Li Xin ^a   Cui, Lan Ying ^a   Wang, Lan Feng ^a   Li, Hong Yuan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Atherosclerosis; Infection; Influenza virus

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RUBELLA ANTIBODY; VIRUS ANTIBODY;

ACUTE HEART INFARCTION; ADENOVIRUS; ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CHLAMYDOPHILA PNEUMONIAE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DEMOGRAPHY; DIET RESTRICTION; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK ASSESSMENT; RUBELLA;

ADULT; AGED; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

ADENOVIRIDAE; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 1; INFLUENZAVIRUS A; INFLUENZAVIRUS B; ORTHOMYXOVIRIDAE; RUBELLA VIRUS;

EID: 47549105879     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-008-9074-2     Document Type: Article

References (29)

1. R. Ross 1999 Atherosclerosis: an inflammatory disease N. Engl. J. Med 340 115 126
2. S. E. Epstein Y. F. Zhou J. Zhu 1999 Infection and atherosclerosis: emerging mechanistic paradigms Circulation 100 e20 e28
3. P. Saikku 2002 Seroepidemiology in Chlamydia pneumoniae-atherosclerosis association Eur. Heart. J 23 263 264
4. C. C. Kuo A. Shor L. A. Campbell H. Fukushi D. L. Patton J. T. Grayston 1993 Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries J. Infect. Dis 167 841 849
5. T. Oshima R. Ozono Y. Yano Y. Oishi H. Teragawa Y. Higashi M. Yoshizumi M. Kambe 2005 Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects J. Am. Coll. Cardiol 45 1219 1222
6. B. Chiu 1999 Multiple infections in carotid atherosclerotic plaques Am. Heart J 138 S534 S536
7. R. G. Deshpande M. B. Khan C. A. Genco 1998 Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis Infect. Immunol 66 5337 5343
8. F. J. Nieto E. Adam P. Sorlie H. Farzadegan J. L. Melnick G. W. Comstock M. Szklo 1996 Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis Circulation 94 922 927
9. D. S. Siscovick S. M. Schwartz L. Corey J. T. Grayston R. Ashley S. P. Wang B. M. Psaty R. P. Tracy L. H. Kuller R. A. Kronmal 2000 Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the Cardiovascular Health Study Circulation 102 2335 2340
10. J. Zhu F. J. Nieto B. D. Horne J. L. Anderson J. B. Muhlestein S. E. Epstein 2001 Prospective study of pathogen burden and risk of myocardial infarction or death Circulation 103 45 51
11. J. Zhu A. A. Quyyumi J. E. Norman R. Costello G. Csako S. E. Epstein 2000 The possible role of hepatitis A virus in the pathogenesis of atherosclerosis J. Infect. Dis 182 1583 1587
12. J. Auer R. Berent T. Weber B. Eber 2002 Influenza virus infection, infectious burden, and atherosclerosis Stroke 33 1454 1455
13. P. Lavallée V. Perchaud M. Gautier-Bertrand D. Grabli P. Amarenco 2002 Association between influenza vaccination and reduced risk of brain infarction Stroke 33 513 518
14. J. Auer M. Leitinger R. Berent W. Prammer T. Weber E. Lassnig B. Eber 2002 Influenza A and B IgG seropositivity and coronary atherosclerosis assessed by angiography Heart Dis 4 349 354
15. M. Madjid M. Naghavi S. Litovsky S. W. Casscells 2003 Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies Circulation 108 2730 2736
16. S. D. Collins 1932 Excess mortality from causes other than influenza and pneumonia during influenza epidemics Pub. Health Rep 47 2159 2180
17. P. A. Gross A. W. Hermogenes H. S. Sacks J. Lau R. A. Levandowski 1995 The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature Ann. Intern. Med 123 518 527
18. J. S. Alpert K. Thygesen E. Antman J. P. Bassand 2000 Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of Myocardial Infarction J. Am. Coll. Cardiol 36 959 969
19. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 2003 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 26 S5 S20
20. J. A. Whitworth World Health Organization, International Society of Hypertension Writing Group 2003 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension J. Hypertens 21 1983 1992
21. M. Naghavi Z. Barlas S. Siadaty S. Naguib M. Madjid W. Casscells 2000 Association of influenza vaccination and reduced risk of recurrent myocardial infarction Circulation 102 3039 3045
22. B. J. Van Lenten A. C. Wagner D. P. Nayak S. Hama M. Navab A. M. Fogelman 2001 High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection Circulation 103 2283 2288
23. B. J. Van Lenten A. C. Wagner G. M. Anantharamaiah D. W. Garber M. C. Fishbein L. Adhikary D. P. Nayak S. Hama M. Navab A. M. Fogelman 2002 Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide Circulation 106 1127 1132
24. J. J. Bouwman F. L. Visseren M. C. Bosch K. P. Bouter R. J. Diepersloot 2002 Procoagulant and inflammatory response of virus-infected monocytes Eur. J. Clin. Invest 32 759 766
25. F. L. Visseren J. J. Bouwman K. P. Bouter R. J. Diepersloot P. H. de Groot D. W. Erkelens 2000 Procoagulant activity of endothelial cells after infection with respiratory viruses Thromb. Haemost 84 319 324
26. M. Naghavi P. Wyde S. Litovsky M. Madjid A. Akhtar S. Naguib M. S. Siadaty S. Sanati W. Casscells 2003 Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice Circulation 107 762 768
27. K. L. Nichol J. Nordin J. Mullooly R. Lask K. Fillbrandt M. Iwane 2003 Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly N. Engl. J. Med 348 1322 1332
28. E. P. Gurfinkel R. L. de la Fuente O. Mendiz B. Mautner 2002 Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study Circulation 105 2143 2147
29. M. M. Davis K. Taubert A. L. Benin D. W. Brown G. A. Mensah L. M. Baddour S. Dunbar H. M. Krumholz American Heart Association American College of Cardiology 2006 Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/ American College of Cardiology Circulation 114 1549 1553